ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
8
views
0
references
Top references
cited by
0
Cite as...
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
2
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
299
similar
All similar
Record
: found
Abstract
: found
Article
: found
Abstracts :
editorial
Publication date
(Print):
2015
Journal:
VASA
Publisher:
Hogrefe AG, Bern
Read this article at
ScienceOpen
Publisher
Further versions
open (via free pdf)
Powered by
Review
Review article
Invite someone to review
Bookmark
Cite as...
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Hogrefe Medicine
Author and article information
Journal
Journal ID (publisher):
vas
Title:
VASA
Publisher:
Hogrefe AG, Bern
ISSN (Print):
0301-1526
ISSN (Electronic):
1664-2872
Publication date (Print):
2015
Volume
: 44
Pages
: 6-48
Article
ApaID ID:
vas_44_s89_6
DOI:
10.1024/0301-1526/a000480
SO-VID:
4ae26105-530a-49b7-a472-1eed04603f65
Copyright ©
Distributed under the Hogrefe OpenMind License (http://dx.doi.org/10.1024/0301-1526/a000480)
History
Categories
Subject:
Abstracts
ScienceOpen disciplines:
Medicine
Data availability:
ScienceOpen disciplines:
Medicine
Comments
Comment on this article
Sign in to comment
scite_
Similar content
299
CONSORT Statement for Randomized Trials of Nonpharmacologic Treatments: A 2017 Update and a CONSORT Extension for Nonpharmacologic Trial Abstracts.
Authors:
David Moher
,
Philippe Ravaud
,
Kenneth F Schulz
…
Linguistic signatures of regulatory focus: how abstraction fits promotion more than prevention.
Authors:
Julian P. T. Higgins
,
C Montes
,
Gün R. Semin
…
Abstract GS3-01: GS3-01 EMERALD phase 3 trial of elacestrant versus standard of care endocrine therapy in patients with ER+/HER2- metastatic breast cancer: Updated results by duration of prior CDK4/6i in metastatic setting
Authors:
Aditya Bardia
,
Francois-Clement Bidard
,
Patrick Neven
…
See all similar